These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7745694)

  • 1. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
    Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F
    J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
    Schuh T; Schultz J; Moelling K; Pavlovic J
    Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
    Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
    J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudotype formation with La Crosse virus glycoproteins.
    Bupp K; González-Scarano F
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():667-71. PubMed ID: 9568959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
    López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
    J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
    Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the intracellular transport properties of recombinant La Crosse virus glycoproteins.
    Bupp K; Stillmock K; González-Scarano F
    Virology; 1996 Jun; 220(2):485-90. PubMed ID: 8661399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological responses of mice and cattle to baculovirus-expressed F and H proteins of rinderpest virus: lack of protection in the presence of neutralizing antibody.
    Bassiri M; Ahmad S; Giavedoni L; Jones L; Saliki JT; Mebus C; Yilma T
    J Virol; 1993 Mar; 67(3):1255-61. PubMed ID: 8437215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
    Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
    J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice.
    Operschall E; Schuh T; Heinzerling L; Pavlovic J; Moelling K
    J Clin Virol; 1999 Jun; 13(1-2):17-27. PubMed ID: 10405888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies directed against the envelope glycoproteins of La Crosse virus.
    Ludwig GV; Israel BA; Christensen BM; Yuill TM; Schultz KT
    Microb Pathog; 1991 Dec; 11(6):411-21. PubMed ID: 1795631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccination against La Crosse virus.
    Pavlovic J; Schultz J; Hefti HP; Schuh T; Mölling K
    Intervirology; 2000; 43(4-6):312-21. PubMed ID: 11251387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion.
    Jacoby DR; Cooke C; Prabakaran I; Boland J; Nathanson N; Gonzalez-Scarano F
    Virology; 1993 Apr; 193(2):993-6. PubMed ID: 8460503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus.
    Jones L; Giavedoni L; Saliki JT; Brown C; Mebus C; Yilma T
    Vaccine; 1993; 11(9):961-4. PubMed ID: 8212844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune response to La Crosse virus infection.
    Taylor KG; Peterson KE
    J Neurovirol; 2014 Apr; 20(2):150-6. PubMed ID: 23846288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
    Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E
    Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.